Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...

Chinese Patent Approved Covering HT-KIT Technology Designed to Induce Cancer Cell Apoptosis, Expanding Protection in One of the World's Largest Oncology Markets NEW YORK, Jan. 21, 2026 /PRNewswire/ -- ...

The very high death toll amongst pigs infected with African Swine Fever virus (ASFv) in pigs could be very well related to ...

Scientists are unraveling the role of senescent cells in a common form of epilepsy, and it could point to new treatments.

Scientific consensus on the biological mechanisms underpinning sunburn has remained largely unchanged for decades. The ...

A laser. A droplet. Then a 10-micron elephant is born, inside a cell. This isn't science fiction. It's already happening.

Agenus Inc. , a leader in immuno-oncology innovation, today announced the expansion of its global Medical Affairs infrastructure and early-access support capabilities in response to increasing ...

The interferon regulatory factor (IRF) family of transcription factors, pivotal for initiating antiviral type I interferon ...

Combination therapy of botensilimab (BOT) plus balstilimab (BAL) was approved Monday as an updated national treatment protocol for patients with certain ovarian cancers and soft tissue sarcomas (STS) ...

Published on January 6, 2026, in Volume 2 of the Immunity & Inflammation journal, the review begins by underscoring Professor Taniguchi's ...

Moderna & Merck announce 5-year data for intismeran autogene in combo with Keytruda demonstrated sustained improvement in primary endpoint of recurrence-free survival in patients with high-risk stage ...

The collaboration provides Agenus with strategic capital and committed, long-term biologics manufacturing capacity in the United States to support BOT+BAL clinical development, authorized early access ...